Table 3 Effect modification by age of randomization in the assessment of the effect of neonatal BCG at birth on T and B cel subsets. 

Cell subsets (%)

26^d

35

19

20

  Tregs

9.1

7.5

7.5

8.9

1.22

(1.03–1.43)

0.84

(0.68–1.03)

0.007

  TH 17 cells

0.6

0.6

0.9

0.6

1.01

(0.73–1.40)

1.42

(0.95–2.11)

0.19

  TC 17 cells

1.5

1.8

1.7

1.6

0.85

(0.63–1.15)

1.08

(0.74–1.55)

0.33

  CD19 + CD24^high + CD38^high

77

60

76

81

1.02

(0.98–1.06)

0.94

(0.89–0.99)

0.02

29

33

22

16

  Tregs

7.5

7.0

7.0

7.8

1.06

(0.96–1.18)

0.90

(0.79–1.02)

0.04

  TH 17 cells

1.5

1.5

1.6

1.2

1.02

(0.84–1.24)

1.40

(1.11–1.79)

0.04

  TC 17 cells

0.9

1.1

1.1

0.9

0.80

(0.61–1.05)

1.17

(0.84–1.63)

0.9

  CD19 + CD24^high + CD38^high

35

36

34

34

0.97

(0.81–1.15)

1.00

(0.81–1.23)

0.83

29

34

22

15

  Tregs

7.9

7.2

7.5

8.2

1.10

(1.00–1.22)

0.91

(0.80–1.04)

0.02

  TH 17 cells

2.3

2.2

2.5

2.1

1.05

(0.87–1.26)

1.15

(0.89–1.47)

0.56

  TC 17 cells

0.8

0.8

0.8

0.7

1.00

(0.76–1.33)

1.15

(0.80–1.69)

0.54

  CD19 + CD24^high + CD38^high

20

18

18

19

1.11

(0.95–1.30)

0.95

(0.77–1.17)

0.24